Cargando…
Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004
BACKGROUND: Retinoblastoma is an eye tumour of childhood that occurs in heritable and non-heritable forms. In the heritable form, there is a predisposition to the development of non-ocular subsequent primary tumours (SPTs). METHODS: This study included 1927 retinoblastoma patients diagnosed in Brita...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694232/ https://www.ncbi.nlm.nih.gov/pubmed/23674091 http://dx.doi.org/10.1038/bjc.2013.228 |
_version_ | 1782274834008375296 |
---|---|
author | MacCarthy, A Bayne, A M Brownbill, P A Bunch, K J Diggens, N L Draper, G J Hawkins, M M Jenkinson, H C Kingston, J E Stiller, C A Vincent, T J Murphy, M F G |
author_facet | MacCarthy, A Bayne, A M Brownbill, P A Bunch, K J Diggens, N L Draper, G J Hawkins, M M Jenkinson, H C Kingston, J E Stiller, C A Vincent, T J Murphy, M F G |
author_sort | MacCarthy, A |
collection | PubMed |
description | BACKGROUND: Retinoblastoma is an eye tumour of childhood that occurs in heritable and non-heritable forms. In the heritable form, there is a predisposition to the development of non-ocular subsequent primary tumours (SPTs). METHODS: This study included 1927 retinoblastoma patients diagnosed in Britain from 1951 to 2004. Ascertainment was through the (UK) National Registry of Childhood Tumours; cases were followed-up for the occurrence of SPTs. Standardised incidence ratios (SIRs) were calculated. RESULTS: We identified 169 SPTs in 152 patients. The SIR analysis included 145 SPTs with cancer registrations from the years 1971 to 2009. These tumours occurred in 132 patients: 112 of the 781 heritable and 20 of the 1075 (presumed) non-heritable cases under surveillance at the start of this period developed at least one registered SPT. The SIRs for all tumours combined were 13.7 (95% confidence interval 11.3–16.5) in heritable cases and 1.5 (0.9–2.3) in non-heritable cases. The main types of SPT in the heritable cases were leiomyosarcoma, (31 cases; SIR 1018.7 (692.2–1446.0)), osteosarcoma (26 cases; SIR 444.6 (290.4–651.4)), and skin melanoma (12 cases; SIR 18.6 (9.6–32.4)). CONCLUSION: The risk of SPTs in heritable retinoblastoma is extremely high. This has important implications for the clinical follow-up and counselling of survivors and their families. |
format | Online Article Text |
id | pubmed-3694232 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-36942322014-06-25 Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004 MacCarthy, A Bayne, A M Brownbill, P A Bunch, K J Diggens, N L Draper, G J Hawkins, M M Jenkinson, H C Kingston, J E Stiller, C A Vincent, T J Murphy, M F G Br J Cancer Clinical Study BACKGROUND: Retinoblastoma is an eye tumour of childhood that occurs in heritable and non-heritable forms. In the heritable form, there is a predisposition to the development of non-ocular subsequent primary tumours (SPTs). METHODS: This study included 1927 retinoblastoma patients diagnosed in Britain from 1951 to 2004. Ascertainment was through the (UK) National Registry of Childhood Tumours; cases were followed-up for the occurrence of SPTs. Standardised incidence ratios (SIRs) were calculated. RESULTS: We identified 169 SPTs in 152 patients. The SIR analysis included 145 SPTs with cancer registrations from the years 1971 to 2009. These tumours occurred in 132 patients: 112 of the 781 heritable and 20 of the 1075 (presumed) non-heritable cases under surveillance at the start of this period developed at least one registered SPT. The SIRs for all tumours combined were 13.7 (95% confidence interval 11.3–16.5) in heritable cases and 1.5 (0.9–2.3) in non-heritable cases. The main types of SPT in the heritable cases were leiomyosarcoma, (31 cases; SIR 1018.7 (692.2–1446.0)), osteosarcoma (26 cases; SIR 444.6 (290.4–651.4)), and skin melanoma (12 cases; SIR 18.6 (9.6–32.4)). CONCLUSION: The risk of SPTs in heritable retinoblastoma is extremely high. This has important implications for the clinical follow-up and counselling of survivors and their families. Nature Publishing Group 2013-06-25 2013-05-14 /pmc/articles/PMC3694232/ /pubmed/23674091 http://dx.doi.org/10.1038/bjc.2013.228 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Clinical Study MacCarthy, A Bayne, A M Brownbill, P A Bunch, K J Diggens, N L Draper, G J Hawkins, M M Jenkinson, H C Kingston, J E Stiller, C A Vincent, T J Murphy, M F G Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004 |
title | Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004 |
title_full | Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004 |
title_fullStr | Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004 |
title_full_unstemmed | Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004 |
title_short | Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004 |
title_sort | second and subsequent tumours among 1927 retinoblastoma patients diagnosed in britain 1951–2004 |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694232/ https://www.ncbi.nlm.nih.gov/pubmed/23674091 http://dx.doi.org/10.1038/bjc.2013.228 |
work_keys_str_mv | AT maccarthya secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004 AT bayneam secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004 AT brownbillpa secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004 AT bunchkj secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004 AT diggensnl secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004 AT drapergj secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004 AT hawkinsmm secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004 AT jenkinsonhc secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004 AT kingstonje secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004 AT stillerca secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004 AT vincenttj secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004 AT murphymfg secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004 |